MetaCap

Zoar Limited (ZOAR)

NYSE: ZOARHealthcareDrug Manufacturers - GeneralUSD

3.38-0.98 (-22.48%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

ZOAR stock chart

Technical analysis

Key statistics

All statistics
Market cap
$608.40M
52-week range
3.26 – 6.72
Day range
3.26 – 4.05
Volume / Avg
21.95K / 31.40K
Beta
—

52-week range

$3.26$6.72

ZOAR stock today

On Nov 20, ZOAR ended the session at $3.38, shedding $0.98 (22.48%), versus the S&P 500's 3.70% decline. At this level, ZOAR sits near the bottom of its 52-week range of $3.26 to $6.72: 49.7% below the high, set on Nov 18, 2026 and 3.7% above the low. Zoar trades at 7.9x its trailing twelve-month earnings per share of $0.43.

Summary generated from market data by MetaCap's automated system. Methodology

About Zoar

Company profile

Zoar Limited, a pharmaceutical company, engages in the development, manufacturing, and distribution of pharmaceutical ingredients (APIs) and intermediates in Africa, the Middle East, India, Central and South America, Asia, and Europe. The company offers APIs for anti-cancer, respiratory diseases, malaria, and cardiovascular health; and orphan drugs for rare diseases. It also provides drug contract development and manufacturing services to pharmaceutical companies.

Industry
Drug Manufacturers - General
Headquarters
Hung Hom
IPO year
2026

ZOAR news

All ZOAR news

Indexes, lists and sector

Appears in lists

Largest Healthcare stocks

Zoar stock FAQ

What is Zoar's stock price today?

ZOAR last traded at $3.38 as of Nov 20, 4:00 PM EST, down 22.48% on the day. Prices are delayed at least 15 minutes.

What is ZOAR's P/E ratio?

ZOAR trades at a trailing P/E ratio of 7.86.

What is the ZOAR 52-week high?

The 52-week high for ZOAR is $6.72 and the 52-week low is $3.26. The stock is currently 49.7% below its high.